QQQ   315.85 (+0.97%)
AAPL   122.95 (+1.62%)
MSFT   233.15 (+1.82%)
FB   262.81 (+3.19%)
GOOGL   2,030.92 (+0.74%)
AMZN   3,080.56 (+0.77%)
TSLA   674.79 (-1.09%)
NVDA   548.98 (+3.13%)
BABA   240.71 (+0.22%)
CGC   32.64 (-1.72%)
GE   12.71 (-0.39%)
MU   91.52 (+3.86%)
NIO   46.38 (-0.92%)
AMD   84.46 (+2.48%)
T   28.05 (-2.03%)
F   11.82 (+0.51%)
ACB   10.69 (-1.20%)
DIS   189.67 (-0.69%)
BA   212.55 (-1.80%)
NFLX   545.01 (-0.31%)
BAC   34.95 (-2.73%)
QQQ   315.85 (+0.97%)
AAPL   122.95 (+1.62%)
MSFT   233.15 (+1.82%)
FB   262.81 (+3.19%)
GOOGL   2,030.92 (+0.74%)
AMZN   3,080.56 (+0.77%)
TSLA   674.79 (-1.09%)
NVDA   548.98 (+3.13%)
BABA   240.71 (+0.22%)
CGC   32.64 (-1.72%)
GE   12.71 (-0.39%)
MU   91.52 (+3.86%)
NIO   46.38 (-0.92%)
AMD   84.46 (+2.48%)
T   28.05 (-2.03%)
F   11.82 (+0.51%)
ACB   10.69 (-1.20%)
DIS   189.67 (-0.69%)
BA   212.55 (-1.80%)
NFLX   545.01 (-0.31%)
BAC   34.95 (-2.73%)
QQQ   315.85 (+0.97%)
AAPL   122.95 (+1.62%)
MSFT   233.15 (+1.82%)
FB   262.81 (+3.19%)
GOOGL   2,030.92 (+0.74%)
AMZN   3,080.56 (+0.77%)
TSLA   674.79 (-1.09%)
NVDA   548.98 (+3.13%)
BABA   240.71 (+0.22%)
CGC   32.64 (-1.72%)
GE   12.71 (-0.39%)
MU   91.52 (+3.86%)
NIO   46.38 (-0.92%)
AMD   84.46 (+2.48%)
T   28.05 (-2.03%)
F   11.82 (+0.51%)
ACB   10.69 (-1.20%)
DIS   189.67 (-0.69%)
BA   212.55 (-1.80%)
NFLX   545.01 (-0.31%)
BAC   34.95 (-2.73%)
QQQ   315.85 (+0.97%)
AAPL   122.95 (+1.62%)
MSFT   233.15 (+1.82%)
FB   262.81 (+3.19%)
GOOGL   2,030.92 (+0.74%)
AMZN   3,080.56 (+0.77%)
TSLA   674.79 (-1.09%)
NVDA   548.98 (+3.13%)
BABA   240.71 (+0.22%)
CGC   32.64 (-1.72%)
GE   12.71 (-0.39%)
MU   91.52 (+3.86%)
NIO   46.38 (-0.92%)
AMD   84.46 (+2.48%)
T   28.05 (-2.03%)
F   11.82 (+0.51%)
ACB   10.69 (-1.20%)
DIS   189.67 (-0.69%)
BA   212.55 (-1.80%)
NFLX   545.01 (-0.31%)
BAC   34.95 (-2.73%)
Log in
NASDAQ:FIXX

Homology Medicines SEC Filings & 10K Form

$10.53
-0.31 (-2.86 %)
(As of 02/26/2021 01:47 PM ET)
Add
Compare
Today's Range
$10.30
Now: $10.53
$11.05
50-Day Range
$11.22
MA: $12.97
$14.80
52-Week Range
$8.70
Now: $10.53
$22.38
Volume21,465 shs
Average Volume333,320 shs
Market Capitalization$476.63 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.24

SEC Filings

Homology Medicines (NASDAQ:FIXX) SEC Filings

DateFilerForm TypeView
02/16/2021
5:28 AM
5AM Ventures IV, L.P. (Filed by)
Homology Medicines (Subject)
Form SC 13G/A
02/09/2021
3:25 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:24 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:22 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:22 PM
Cohn Gabriel (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
3:07 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
5:31 AM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
1:56 PM
BlackRock Inc. (Filed by)
Homology Medicines (Subject)
Form SC 13G
01/25/2021
12:22 PM
Homology Medicines (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
01/08/2021
3:05 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
3:05 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:01 AM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2020
8:37 PM
Homology Medicines (Issuer)
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
8:35 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
8:35 PM
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:01 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
6:25 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
6:15 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:13 PM
Homology Medicines (Subject)
PFIZER INC (Filed by)
Form SC 13G
11/09/2020
3:02 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
7:26 AM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:02 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2020
4:31 PM
Homology Medicines (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
4:30 PM
Homology Medicines (Issuer)
Poulton Jeffrey V. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/21/2020
4:20 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
4:33 PM
Homology Medicines (Issuer)
REICIN ALISE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:31 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:27 PM
Gregory Richard J. (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:27 PM
Homology Medicines (Issuer)
Thistle Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:27 PM
Homology Medicines (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:25 PM
GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:21 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2020
7:31 AM
Flynn James E (Filed by)
Homology Medicines (Subject)
Form SC 13D/A
04/20/2020
7:30 AM
Flynn James E (Filed by)
Homology Medicines (Subject)
Form SC 13D/A
03/18/2020
4:32 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
4:00 PM
Homology Medicines (Filer)
Form S-3ASR
03/10/2020
11:20 AM
Homology Medicines (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13G/A
02/13/2020
3:51 PM
ARCH Venture Fund VIII, L.P. (Filed by)
Homology Medicines (Subject)
Form SC 13G/A
01/31/2020
3:19 PM
Flynn James E (Filed by)
Homology Medicines (Subject)
Form SC 13D/A
01/31/2020
3:17 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
5:43 PM
Gregory Richard J. (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
5:38 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
10:01 AM
Homology Medicines (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
01/03/2020
4:36 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
4:33 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
4:32 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
9:10 AM
Homology Medicines (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
12/30/2019
7:30 AM
Flynn James E (Filed by)
Homology Medicines (Subject)
Form SC 13D/A
12/27/2019
6:09 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
6:57 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
8:30 AM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
3:07 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:07 PM
Cohn Gabriel (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:06 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:07 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:05 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:42 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:40 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:39 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:01 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
3:18 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:16 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
4:36 PM
Homology Medicines (Issuer)
REICIN ALISE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
4:35 PM
Homology Medicines (Issuer)
REICIN ALISE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2019
4:15 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:30 PM
Homology Medicines (Issuer)
Rasty Siyamak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:32 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:30 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:45 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
6:33 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 4/A
06/11/2019
3:47 PM
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Gregory Richard J. (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Homology Medicines (Issuer)
Thistle Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:10 PM
Homology Medicines (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:09 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:09 PM
GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:05 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
5:16 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:13 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:11 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:10 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:09 PM
Homology Medicines (Issuer)
Rasty Siyamak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:58 PM
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund VIII, L.P. (Reporting)
ARCH Venture Partners VIII, L.P. (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Homology Medicines (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:26 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:24 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
3:03 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:57 PM
Homology Medicines (Filer)
Form DEFA14A
04/25/2019
3:54 PM
Homology Medicines (Filer)
Form DEF 14A
04/15/2019
6:38 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:21 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
4:18 PM
Homology Medicines (Filer)
Form 424B5
04/09/2019
11:15 PM
Homology Medicines (Filer)
Form EFFECT
04/08/2019
3:51 PM
Homology Medicines (Filer)
Form 424B5
04/08/2019
3:48 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
4:29 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:46 PM
Homology Medicines (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2019
6:01 AM
Homology Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
2:10 PM
ARCH Venture Fund VIII, L.P. (Filed by)
Homology Medicines (Subject)
Form SC 13G
02/04/2019
3:05 PM
Homology Medicines (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13G
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.